Developmental Deconvolution for Classification of Cancer Origin is a dataset published in Cancer Discovery (2022). On theSindex it has a DataRank of 0.919, placing it in the top 22% of the data-sharing corpus. It has been cited 32 times, with 26 citing works in its 1-hop citation network.
Ranks in the top 22% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.524
From this paper's citation signal
Citation Network Contribution
0.394
From 15 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 26 citers.
National Institutes of Health
Grant: NCI K08-CA237856
National Institutes of Health
Grant: NCI P30-CA14051
National Institutes of Health
Grant: NCI R37-CA225655
Ludwig Family Foundation
Grant: fellowship
NCI NIH HHS
Grant: R37 CA225655
NCI NIH HHS
Grant: P30 CA014051
NCI NIH HHS
Grant: K08 CA237856
FWCI
2.52
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
Additional file 1 of Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
Additional file 3 of Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
Additional file 3 of Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
Additional file 2 of Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
Additional file 2 of Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma